Results 21 to 30 of about 2,204,307 (197)

Mechanisms of Pyrazinamide Action and Resistance [PDF]

open access: yesMicrobiology Spectrum, 2014
ABSTRACT Pyrazinamide (PZA) is a unique antituberculosis (anti-TB) drug that plays a key role in shortening TB therapy. PZA kills nonreplicating persisters that other TB drugs fail to kill, which makes it an essential drug for inclusion in any drug combinations for treating drug-susceptible and drug-resistant TB such as multidrug-
Ying, Zhang   +3 more
openaire   +3 more sources

Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line [PDF]

open access: yesGenetics and Molecular Biology, 2023
Genetically antimicrobial resistance in Mycobacterium tuberculosis is currently one of the most important aspects of tuberculosis, considering that there are emerging resistant strains for almost every known drug used for its treatment.
Nicolas de Oliveira Rossini   +1 more
doaj   +1 more source

Pyrazinamide resistance in Swedish multidrug-resistant tuberculosis 2003–2013

open access: yesInternational Journal of Mycobacteriology, 2015
Aims and objectives: The aim of this study is to determine the prevalence of pyrazinamide (PZA) resistance among multidrug-resistant Mycobacterium tuberculosis (MDR-TB) strains isolated in Sweden between 2003 and 2013 and to study the correlation between
M Mansjö, J Werngren, S Hoffner
doaj   +2 more sources

Pyrazinamide resistance of novel mutations in pncA and their dynamic behavior. [PDF]

open access: yesRSC Adv, 2020
We performed several analyses to unveil the pyrazinamide-resistance mechanism of R123P, T76P, G150A, and H71R mutants through molecular dynamics simulations.
Ali A   +7 more
europepmc   +4 more sources

Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.

open access: yesPLoS ONE, 2022
BackgroundEthiopia is one of the high multidrug-resistant tuberculosis (MDR-TB) burden countries. However, phenotypic drug susceptibility testing can take several weeks due to the slow growth of Mycobacterium tuberculosis complex (MTBC) strains.
Eyob Abera Mesfin   +7 more
doaj   +1 more source

Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China

open access: yesFrontiers in Microbiology, 2021
Pyrazinamide (PZA) is widely used to treat drug-sensitive or multidrug resistance tuberculosis. However, conventional PZA susceptibility tests of clinical isolates are rather difficult because of the requirement of acid pH.
Kun Li   +6 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

The study of cross-resistance of MTB to certain anti-tuberculosis drugs among tuberculosis patients in Tomsk Region

open access: yesТуберкулез и болезни лёгких, 2020
The objective of the study: to assess the prevalence of drug resistance of tuberculous mycobacteria (MTB) to pyrazinamide, linezolid, cross-resistance to fluoroquinolones, and cross-resistance to injectable anti-tuberculosis drugs among tuberculosis ...
P. N. Golubchikov   +5 more
doaj   +1 more source

Counting Pyrazinamide in Regimens for Multidrug-Resistant Tuberculosis [PDF]

open access: yesAnnals of the American Thoracic Society, 2015
Abstract Rationale For treatment of multidrug-resistant tuberculosis, World Health Organization (WHO) guidelines recommend four likely effective drugs plus pyrazinamide (PZA), irrespective of the likely effectiveness of PZA in an individual patient.
Molly F, Franke   +7 more
openaire   +2 more sources

Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan [PDF]

open access: yesThe International Journal of Tuberculosis and Lung Disease, 2018
The World Health Organization (WHO) recommends the inclusion of pyrazinamide (PZA) in treatment regimens for multidrug-resistant tuberculosis (MDR-TB) unless resistance has been confirmed.To investigate the association between PZA susceptibility and MDR-TB treatment outcome among patients treated with a PZA-containing regimen and whether the duration ...
Kuhlin, J   +10 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy